These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15974027)

  • 1. Beating the odds. Finely tuned diagnoses and targeted drugs are creating optimism about surviving breast cancer.
    Hobson K
    US News World Rep; 2005 Jun; 138(22):62-4, 67-8, 70. PubMed ID: 15974027
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted therapy: wave of the future.
    Pegram MD; Pietras R; Bajamonde A; Klein P; Fyfe G
    J Clin Oncol; 2005 Mar; 23(8):1776-81. PubMed ID: 15755985
    [No Abstract]   [Full Text] [Related]  

  • 3. What is targeted therapy?
    Sledge GW
    J Clin Oncol; 2005 Mar; 23(8):1614-5. PubMed ID: 15755966
    [No Abstract]   [Full Text] [Related]  

  • 4. Second-line treatment of postmenopausal women with advanced breast carcinoma.
    Board RE; Dean EJ; Mitchell C; Wardley AM
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):613-24. PubMed ID: 16613548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer.
    Yang J; Lee CH; Ko HJ; Suh JS; Yoon HG; Lee K; Huh YM; Haam S
    Angew Chem Int Ed Engl; 2007; 46(46):8836-9. PubMed ID: 17943947
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemo in question. Higher doses may not help breast cancer--yet.
    Underwood A
    Newsweek; 1999 Apr; 133(17):64. PubMed ID: 10351750
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer: beyond the cutting edge.
    Higa GM
    Expert Opin Pharmacother; 2009 Oct; 10(15):2479-98. PubMed ID: 19761355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letrozole as adjuvant therapy for postmenopausal women with early breast cancer.
    Russell CA
    Manag Care Interface; 2007 Sep; 20(9):30-1, 36. PubMed ID: 18161388
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer overview.
    Ely S; Vioral AN
    Plast Surg Nurs; 2007; 27(3):128-33; quiz 134-5. PubMed ID: 17901821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic nanoparticle holds promise in blocking aggressive breast cancer.
    Printz C
    Cancer; 2010 Dec; 116(24):5567. PubMed ID: 21218458
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological breast cancer therapy (review).
    Navolanic PM; McCubrey JA
    Int J Oncol; 2005 Nov; 27(5):1341-4. PubMed ID: 16211230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA approves new drug for specific type of advanced breast cancer.
    Mayo Clin Womens Healthsource; 2007 Oct; 11(10):3. PubMed ID: 18418907
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in adjuvant therapy for breast cancer.
    Slamon DJ; Romond EH; Perez EA;
    Clin Adv Hematol Oncol; 2006 Mar; 4(3 Suppl 7):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10. PubMed ID: 16736568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-action drug approved for use in advanced breast cancer.
    McBride D
    ONS Connect; 2007 Jun; 22(6):19. PubMed ID: 17598617
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying breast cancer druggable oncogenic alterations: lessons learned and future targeted options.
    Ocaña A; Pandiella A
    Clin Cancer Res; 2008 Feb; 14(4):961-70. PubMed ID: 18281527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is triple negative a prognostic factor in breast cancer?
    Nishimura R; Arima N
    Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of targeted biologic therapies.
    Sledge GW
    Breast; 2007 Dec; 16 Suppl 2():S1-3. PubMed ID: 17703940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better prioritization may speed approval of adjuvant therapies in breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2008 Jun; 100(12):842-4. PubMed ID: 18544735
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting metastatic and advanced breast cancer.
    Moore S; Cobleigh MA
    Semin Oncol Nurs; 2007 Feb; 23(1):37-45. PubMed ID: 17303515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdc42: an effector and regulator of ErbB1 as a strategic target in breast cancer therapy.
    Hirsch DS; Wu WJ
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):147-57. PubMed ID: 17288526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.